Pexacerfont as a CRF1 antagonist for the treatment of withdrawal symptoms in men with heroin/methamphetamine dependence

Authors

Keywords

Journal

Volume -, Issue -, Pages 1

Publisher

Ovid Technologies (Wolters Kluwer Health)

Online

2017-10-25

DOI

10.1097/yic.0000000000000200

Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.

Upload Now

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started